Heart Disease Home > Betapace Medication Information

Betapace® (sotalol hydrochloride) is a prescription beta blocker medication approved for the treatment of the following conditions:
  • Atrial fibrillation or atrial flutter that causes significant symptoms
  • Life-threatening ventricular arrhythmias.
This medicine comes in different forms. Betapace AF® is approved to treat atrial fibrillation or atrial flutter, while regular Betapace is approved to treat other arrhythmias. Both types come in tablet form and are typically taken by mouth one to three times a day, with the first three days of treatment starting within a hospital or similar facility, where the heart can be continuously monitored.
Because Betapace is not suitable for everyone, it's important to review the safety information for this medication with your healthcare provider before starting treatment. For example, make sure your healthcare provider is aware of any other health issues you may have, such as diabetes, heart failure, or asthma.
(For more information on this medication, including factors that will affect your dose, side effects, and generic availability, click Betapace.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.